NaV1.7 and NaV1.8 Channels: Key Targets for Novel Analgesics

What are NaV1.7 and NaV1.8 Channels?

NaV1.7 and NaV1.8 are specific types of voltage-gated sodium channels that play critical roles in neuronal excitability, particularly in pain pathways. These channels are found predominantly in sensory neurons, where they contribute to the generation and propagation of action potentials.

Research has shown that these channels have distinct expression patterns and functional properties, making them attractive targets for developing novel analgesics without the side effects associated with opioids.

Why Do NaV1.7 and NaV1.8 Channels Matter in Pain Management?

NaV1.7 channels are primarily expressed in small-diameter nociceptors, which are responsible for detecting painful stimuli. By modulating these channels, it is possible to reduce the transmission of pain signals without affecting other sensory functions.

On the other hand, NaV1.8 channels are found in both nociceptive and non-nociceptive neurons but play a more significant role in pain modulation. Targeting these channels can help in managing chronic pain conditions by altering the balance between excitation and inhibition within the nervous system.

How Do Analgesics Target NaV1.7 and NaV1.8 Channels?

Analgesic drugs designed to target NaV1.7 channels typically work by stabilizing the closed state of these channels, thereby reducing the frequency of action potentials in nociceptors. This mechanism can effectively block pain signals without affecting other sensory functions.

For NaV1.8 channels, analgesics often act as modulators that enhance the inhibitory effects on neuronal excitability. By increasing the threshold for activation or prolonging the inactivated state, these drugs can reduce pain perception while maintaining normal sensory function.

Real-World Applications and Future Prospects

The development of selective inhibitors for NaV1.7 and NaV1.8 channels represents a promising approach in the field of non-opioid analgesics. These drugs could provide effective pain relief with reduced risk of addiction, tolerance, and side effects commonly associated with traditional opioid-based therapies.

Current research is focused on optimizing these compounds to achieve better selectivity and efficacy, paving the way for new treatments that can significantly improve patient outcomes in chronic pain management.

Frequently asked questions

Try it live

Everything above runs in your browser — open NaV1.7/NaV1.8 Channel Pain Target Comparison Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.